Stocktoria
Scientist Home Future Health Ltd SHFH
Scientist Home Future Health Ltd (SHFH) earns a Piotroski F-score of 0/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $204,055 at a -113.6% net margin.
How it ranks in Manufacturing · percentile among 2036 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 0/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.034 |
| Retained earnings / assets | -0.383 |
| EBIT / assets | -0.36 |
| Equity / liabilities | 0.214 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| SHFH | Scientist Home Future Health Ltd | 0/9 | -3.67 | — | — |
| CABR | Caring Brands, Inc. | 2/9 | -11.76 | — | — |
| BNKK | BONK, INC. | 4/9 | — | — | — |
| PTNM | Pitanium Ltd | 2/9 | 2.33 | — | -88.7% |
| UG | UNITED GUARDIAN INC | 4/9 | 15.38 | 15.7 | -13.4% |
| AXIL | Axil Brands, Inc. | 6/9 | 7.41 | 16.2 | +17.5% |
| SLSN | SOLESENCE, INC. | 3/9 | -4.89 | 32.6 | +18.6% |
About Scientist Home Future Health Ltd
Scientist Home Future Health Limited engages in the retail trading of health supplements and topical creams in Hong Kong and internationally. The company offers Scientist Home Vein Cream, for supporting vein health; Scientist Home Calcification Cream for addressing calcification problems associated with bone, joint and muscle health, as well as the cardiovascular system; and Scientist Home Spermaceti Cream, which targets joint and muscle discomfort for arthritis, tendon and ligament strains, and minor sprains and bruises. It also provides Scientist Home Bone Gelatine Hydrolysate, a nutritional supplement which helps to maintain and enhance bone and joint health; Scientist Home Mixed Gelatine Hydrolysate, a supplement that promotes bone and joint health; and Scientist Home High Concentration Proteinase, a supplement that supports various health needs, including bone and joint discomfort, muscle tenderness, airway and lung health, digestive health, intestinal and colon health, and soft tissue injury. The company was incorporated in 2024 and is based in Kwun Tong, Hong Kong.
FAQ
Is SHFH financially healthy?
Scientist Home Future Health Ltd's Piotroski F-score is 0/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does SHFH pay a dividend?
No, Scientist Home Future Health Ltd does not currently pay a dividend.
How profitable is SHFH?
In FY2025, Scientist Home Future Health Ltd had a net margin of -113.6% and a return on equity of -204.4%.
Is SHFH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Scientist Home Future Health Ltd: a Piotroski F-score of 0/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.